A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia

Saudi Medical Journal

Volumn 27, Issue 1, 2006, Pages 63-69

  Jaber, Soad M ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; RUBELLA ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ARTICLE; CHILD HEALTH CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; NONHUMAN; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RUBELLA; SAUDI ARABIA; SCHOOL CHILD; SERODIAGNOSIS; URBAN AREA; VACCINATION;

ADOLESCENT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; RISK ASSESSMENT; RUBELLA; SAUDI ARABIA; SEROEPIDEMIOLOGIC STUDIES;

EID: 32044460855     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACID). Morb Mortal Wkly Rep 1998; 47: 1-57.
2. Centers for Disease Control and Prevention. Progress in Reducing Measles Mortality Worldwide, 1999-2003. Morb Mortal Wkly Rep 2005; 54: 200-203.
3. Elliman D, Sengupta N. Measles. Curr Opin Infect Dis 2005; 18: 229-234.
4. De-Serres G, Sciberras J, Naus M, Boulianne N, Duval B, Rochette L. Protection after two doses of measles vaccine is independent of interval doses. J Infect Dis 1999; 180: 187-190.
5. Wagenvoort JHT, Harmsen M, Boutahar-Trouw BJ, Kraaijeveld CA, Winkler KC. Epidemiology of mumps in the Netherlands. J Hyg (Lond) 1980; 85: 313-326.
6. Cox MJ, Anderson RM, Bundy DA, Nokes DJ, Didier JM, Simmons I, et al. Seroepidemiological study of the transmission of the mumps virus in St. Lucia, West Indies. Epidemiol Infect 1989; 102: 147-160.
7. Bakir TMF, Hossain A, Ramia S, Sinha NP. Seroepidemiology of mumps, measles, and subacute sclerosing panencephalitis in Saudi Arabia. J Trop Pediatr 1988; 34: 254-256.
8. Imbs D, Loza-Tulimowska M, Rudnicka H. Occurrence of antibodies against mumps in the population of Poland. Przegl Epidemiol 1984; 38: 361-368.
9. Centers for Disease Control. Mumps: United States. Morb Mortal Wkly Rep 1987; 36: 151-155.
10. Germann D, Strohle K, Eggenberger K, Steiner CE, Matter L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 1996; 28:235-238.
11. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, et al. Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 1993; 341: 979-982.
12. dos Santos DCM, Souto FJD, dos Santos DRL, Vitral CL, Gaspar AMC. Seroepidemiological markers of enterically transmitted viral hepatitis A and E in individuals living in a community located in the north area of Rio de Janeiro, RJ, Brazil. Mem Inst Oswaldo Cruz 2002; 97: 637-640.
13. Data compiled from published Ministry of Health yearly report encompassing years from 1403H to 1412H.
14. Hegazy IS, Al-Beyari TH, Al-Amri AH, Noeman SA, Qureshi NA, Abdelgadir MH. A seroepidemiological study of measles: some practical implications for measles immunization program, Kingdom of Saudi Arabia. Ann Saudi Med 1994; 14: 399-404.
15. Hicks NR. Misplaced loss of confidence in measles vaccination: an investigation in a primary school. JR Coll Gen Pract 1989; 39: 151-152.
16. WHO. Weekly Epidemiological Records. World Health Organization. No. 43.26. October 1990; 334-336. Available at URL://www.kfshrc.edu.sa/ annals/145/93167.html
17. WHO. Weekly epidemiological record. World Health Organization. No. 37-14 September 1990; 284-286. Available at URL://www.kfshrc.edu.sa/annals/145/ 93167.html
18. WHO. Weekly Epidemiological Records. World Health Organization. No.42-19. October 1990: 323-325. Available at URL://www.kfshrc.edu.sa/ annals/145/93167.html
19. WHO. Weekly Epidemiological Record. World Health Organization. No. 49-47. December 1990; 379-381. Available at URL://www.kfshrc.edu.sa/ annals/145/93167.html
20. Markowitz LE, Preblud SR, Fine PEM, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990; 9: 101-110.
21. Shelton JD, Jacobson JE, Orenstein WA, Schultz KF, Donnell HD. Measles vaccine efficacy: influence of age at vaccination vs. duration of time since vaccination. Pediatrics 1978; 62: 961-964.
22. Abanamy A, Khalil M, Salman H, Abdulazeem M. Measles vaccine failure. Ann Saudi Med 1991; 11: 311-314.
23. Anonymous. Measles outbreak - Romania, 1997. Morb Mortal Wkly Rep 1997; 46: 1159-1163.
24. Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 1995; 13: 799-802.
25. Boulianne N, De Serres G, Ratnam S, Ward BJ, Joly JR, Duval B. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination. Vaccine 1995; 13:161-166.
26. Leland DS, Kleiman MB. Mumps virus, In: Smith TF, editor. Laboratory Diagnosis of Viral Infections. Vol. 6. NY (NY): Marcel Dekker Inc; 1999: p. 23-32.
27. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999; 77: 3-14.
28. Nicoara C, Zach K, Trachsel D, Germann D, Matter L. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses. Clin Diagn Lab Immunol 1999; 6: 868-871.
29. Gabutti G, Rota MC, Salmaso S, Bruzzone BM, Bella A, Crovari P. The Serological Study Group. Epidemiology of measles, mumps and rubella in Italy. Epidemiol Infect 2002; 129: 543-550.
30. Amela C, Pachon I, de Ory F. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a seroepidemiological survey. Ear J Epidemiol 2003; 18: 71-79.
31. Watson JC, Hadler SC, Dykewicz CA, Reef S, Philips L. Measles, mumps and rubella - vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendation of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1998; 47: 1-57.
32. Cochi SL, Preblud SR, Orenstein WA. Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child 1988; 142: 499-507.
33. Cutts FT, Robertson SE, Dý'az-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ 1997; 75: 55-68.
34. Dowdle WR, Ferrera W, De Salles Gomes LF, King D, Kourany M, Madalengoitia J, et al. WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ 1970; 42: 419-422.
35. Christenson B, Bottiger M. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated your adults. Vaccine 1994; 12: 41-45.
36. Beckler N, Rouderfer V. Simultaneous control of measles and rubella by multidose vaccination schedules. Math Biosci 1996; 131: 81-102.
37. de Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson Da, Brandling-bennett D, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996; 275: 224-9.
38. Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ 1997; 75: 69-80.